查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
北美基因检测服务市场预测至 2030 年 - 区域分析 - 按服务类型、疾病和服务提供者
市场调查报告书
商品编码
1533072

北美基因检测服务市场预测至 2030 年 - 区域分析 - 按服务类型、疾病和服务提供者

North America Genetic Testing Services Market Forecast to 2030 - Regional Analysis - by Service Type, Disease, and Service Provider
出版日期: | 出版商: The Insight Partners | 英文 101 Pages | 订单完成后即时交付

价格

2022年北美基因检测服务市值为16.0432亿美元，预计到2030年将达到49.8425亿美元；预计2022年至2030年复合年增长率为15.2%。

对直接面向消费者 (DTC) 的基因检测的日益青睐推动了北美基因检测服务市场的发展

个人化基因检测和治疗长期以来在全球范围内使用，以帮助个人和家庭更多地了解遗传性疾病。大多数时候，基因检测是透过医疗保健人员（例如遗传咨询师）完成的。医疗保健提供者决定需要进行哪种测试，从测试中心订购测试，收集并发送 DNA 样本，读取测试结果，并与患者分享结果。因此，这些测试传统上是在临床或医学研究环境中进行排序和解释的。相比之下，DTC 基因检测在过去十年中取得了巨大的成长，并且变得越来越普遍。

由公司直接向消费者提供、宣传和销售的基因测试，无需传统医疗保健系统的直接参与，称为 DTC 基因测试。 DTC 基因检测相对较新，可以帮助人们发现他们可能携带的与疾病相关的基因，而无需遗传咨询师或医生的处方或指导。 DTC 测试的一些消费者将其视为收集有关自己的医疗资讯的另一种方法。

与诊所或医院进行的其他基因测试不同，消费者独立启动并完成 DTC 基因测试。大众对基因检测的理解和接受度正在逐渐提高。此外，越来越多的消费者寻求客製化产品和体验来识别和满足独特需求。创新产品的推出以及 DTC 基因检测试剂盒的采用增加，使基因检测更容易被人们所接受。这些套件使用户能够在舒适的家中进行个人化的健康管理。

主要产业参与者也在开发 DTC 基因测试并实施特殊的行销活动，以对 DTC 测试的销售产生积极影响。 2017 年 4 月，美国食品药物管理局 (FDA) 同意遗传学公司 23andMe 销售 DNA 测试，评估使用者罹患 10 种健康状况的风险水平，包括迟发性阿兹海默症和帕金森氏症。这些仍然是 FDA 批准的唯一针对感染遗传风险的 DTC 测试。 2023年7月，美国诊断资讯服务供应商Quest Diagnostics推出了首款直接面向消费者的基因测试Genetic Insights。该测试使用次世代定序来评估遗传健康状况的风险。此测试使用唾液样本检查 36 个基因。它可以调查多达 24 种遗传性疾病的潜在风险，包括乳癌、心臟病、血液疾病和镰状细胞性贫血。

越来越多的製造商正在提供直接面向消费者的基因检测，涵盖各种健康状况和特征。对直接面向消费者的基因检测产品的需求不断增长，以了解基因组成并评估遗传性疾病的风险，以进行早期疾病检测或预防，这推动了市场的发展。

北美基因检测服务市场概况

北美基因检测服务市场分为美国、加拿大和墨西哥。 2022年，美国在该地区占据最大市场份额，预计2022-2030年将继续保持主导地位。近年来，由于癌症患者数量不断增加、政府资助不断增加以及美国和加拿大人口遗传疾病发病率上升，北美基因检测服务市场预计将增长。此外，对医疗保健中先进方法整合的日益关注、政府和私人促进精准医疗的倡议，以及政府和私人机构为基因研究提供的大量资金，都为北美基因检测服务市场带来了非凡的收入。

北美基因检测服务市场收入及 2030 年预测（百万美元）

北美基因检测服务市场细分

北美基因检测服务市场按服务类型、疾病、服务提供者和国家分类。

根据服务类型，北美基因检测服务市场可细分为预测检测、带因者检测、产前检测、新生儿筛检等。预测测试领域在 2022 年占据最大的市场份额。

从疾病类型来看，北美基因检测服务市场分为癌症、代谢疾病、心血管疾病和其他疾病。 2022 年，癌症细分市场占据最大的市场。

依服务提供者划分，北美基因检测服务市场分为医院实验室、诊断实验室等。 2022 年，医院实验室细分市场占据最大市场份额。

按国家/地区划分，北美基因检测服务市场分为美国、加拿大和墨西哥。 2022年，美国在北美基因检测服务市场占有率中占据主导地位。

23andMe Holding Co、Ambry Genetics Corp、Eurofins Scientific SE、Exact Sciences Corp、F. Hoffmann-La Roche Ltd、Illumina Inc、Laboratory Corp of America Holdings、NeoGenomics Inc、Centogene AG 和Quest Diagnostics Inc 是在这些领域运营的领先公司之一。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美基因检测服务市场 - 主要产业动态

  • 主要市场驱动因素
    • 遗传性疾病盛行率上升
    • 提高对个人化药物的认识和接受度
    • 对直接面向消费者 (DTC) 的基因检测的偏好日益增长
  • 市场限制
    • 基因检测的社会和伦理影响
    • 遗传服务的承受能力
  • 市场机会
    • 发展中国家尚未开发的新兴市场
  • 未来趋势
    • 人工智慧驱动的基因检测
  • 影响分析：

第 5 章：基因检测服务市场 - 北美市场分析

  • 北美基因检测服务市场收入，2022 - 2030

第 6 章：北美基因检测服务市场 - 收入和 2030 年预测 - 按服务类型

  • 概述
  • 北美基因检测服务市场收入份额，按服务类型，2022 年和 2030 年 (%)
  • 预测测试
  • 运营商测试
  • 产前检测
  • 新生儿筛检
  • 其他的

第 7 章：北美基因检测服务市场 - 2030 年收入与预测 - 按疾病分类

  • 概述
  • 北美基因检测服务市场收入份额，按疾病分类，2022 年和 2030 年 (%)
  • 癌症
  • 心血管疾病
  • 代谢性疾病
  • 其他疾病

第 8 章：北美基因检测服务市场 - 收入和 2030 年预测 - 按服务提供者

  • 概述
  • 2022 年和 2030 年北美基因检测服务市场收入份额（按服务提供者划分）（%）
  • 医院实验室
  • 诊断实验室
  • 其他的

第 9 章：北美基因检测服务市场 - 国家分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥

第 10 章：基因检测服务市场-产业格局

  • 概述
  • 基因检测服务市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 11 章：公司简介

  • Eurofins Scientific SE
  • Exact Sciences Corp
  • Laboratory Corp of America Holdings
  • 23andMe Holding Co
  • Ambry Genetics Corp
  • Quest Diagnostics Inc
  • Illumina Inc
  • F. Hoffmann-La Roche Ltd
  • NeoGenomics Inc
  • Centogene AG

第 12 章：附录

Product Code: TIPRE00009262

The North America genetic testing services market was valued at US$ 1,604.32 million in 2022 and is expected to reach US$ 4,984.25 million by 2030; it is estimated to register a CAGR of 15.2% from 2022 to 2030.

Growing Preference for Direct-To-Consumer (DTC) Genetic Testing Fuels North America Genetic Testing Services Market

Personalized genetic testing and treatment have long been used globally to help individuals and families learn more about hereditary diseases. Most of the time, genetic testing is done through healthcare personnel, such as genetic counselors. Healthcare providers decide which test is needed, order the test from a test center, collect and send the DNA sample, read the test results, and share the results with the patient. Thus, these tests have traditionally been ordered and interpreted in a clinical or medical research setting. In contrast, DTC genetic testing has witnessed tremendous growth in the past decade and is becoming increasingly widespread.

A genetic test offered, advertised, and sold by companies directly to the consumer, without the direct involvement of a conventional healthcare system, is called DTC genetic testing. DTC genetic testing is relatively new and helps people find out about the disease-associated genes they may carry without the need for a prescription or guidance from a genetic counselor or medical practitioner. Several consumers of DTC testing view it as another method of gathering medical information about themselves.

Unlike other genetic tests performed in clinics or hospitals, the consumer independently initiates and completes a DTC genetic test. The public understanding and acceptance of genetic testing is gradually increasing. Additionally, there is a rise in consumers seeking customized products and experiences for the identification and addressing of unique needs. The launch of innovative products and the increase in the adoption of DTC genetic testing kits have made genetic testing more accessible to people. These kits enable users to undergo personalized health management within the comfort of their homes.

Key industry players are also developing DTC genetic tests and implementing special marketing efforts that positively impact sales of DTC tests. In April 2017, the US Food and Drug Administration (FDA) gave genetics company 23andMe the consent to market DNA tests evaluating the user's level of risk for ten health conditions, including late-onset Alzheimer's disease and Parkinson's disease. These remain the only FDA-approved DTC tests for genetic risk of infection. In July 2023, Quest Diagnostics, a US-based diagnostic information service provider, introduced its first direct-consumer genetic test, Genetic Insights. The test uses next-generation sequencing to evaluate the risk for inheritable health conditions. The test inspects 36 genes using a saliva sample. It can investigate the potential risk of up to 24 genetically inheritable conditions, including breast cancer, heart disorders, blood disorders, and sickle cell anemia.

A rising number of manufacturers are providing direct-to-consumer genetic testing that covers various health conditions and traits. The increasing demand for direct-to-consumer genetic testing products to learn about the genetic makeup and assess the risk of developing hereditary conditions for early disease detection or prevention drives the market.

North America Genetic Testing Services Market Overview

The North America genetic testing services market in North America is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share in this region and is expected to continue its dominance during 2022-2030. The North America genetic testing services market in North America is expected to grow due to the rising number of cancer patients, increasing government funding, and rising incidence of genetic diseases among the population in the US and Canada during recent years. Moreover, increasing focus on advanced method incorporation in healthcare, government and private initiatives for the promotion of precision medicine, and massive funds from government and private bodies for genetic research contribute to exceptional revenue generation for the North America genetic testing services market in North America.

North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Million)

North America Genetic Testing Services Market Segmentation

The North America genetic testing services market is categorized into service type, disease, service provider, and country.

Based on service type, the North America genetic testing services market is segmented predictive testing, carrier testing, prenatal testing, newborn screening, and others. The predictive testing segment held the largest market share in 2022.

In terms of disease, the North America genetic testing services market is categorized into cancer, metabolic diseases, cardiovascular diseases, and other diseases. The cancer segment held the largest market share in 2022.

By service provider, the North America genetic testing services market is segmented into hospital-based laboratories, diagnostic laboratories, and others. The hospital-based laboratories segment held the largest market share in 2022.

By country, the North America genetic testing services market is segmented into the US, Canada, and Mexico. The US dominated the North America genetic testing services market share in 2022.

23andMe Holding Co, Ambry Genetics Corp, Eurofins Scientific SE, Exact Sciences Corp, F. Hoffmann-La Roche Ltd, Illumina Inc, Laboratory Corp of America Holdings, NeoGenomics Inc, Centogene AG, and Quest Diagnostics Inc are among the leading companies operating in the North America genetic testing services market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Genetic Testing Services Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Rising Prevalence of Genetic Diseases
    • 4.1.2 Increasing Awareness and Acceptance of Personalized Medicines
    • 4.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
  • 4.2 Market Restraints
    • 4.2.1 Social and Ethical Implications of Genetic Testing
    • 4.2.2 Affordability of Genetic Services
  • 4.3 Market Opportunities
    • 4.3.1 Untapped Emerging Markets in Developing Countries
  • 4.4 Future Trends
    • 4.4.1 Artificial Intelligence-Powered Genetic Testing
  • 4.5 Impact Analysis:

5. Genetic Testing Services Market - North America Market Analysis

  • 5.1 North America Genetic Testing Services Market Revenue (US$ Mn), 2022 - 2030

6. North America Genetic Testing Services Market - Revenue and Forecast to 2030 - by Service Type

  • 6.1 Overview
  • 6.2 North America Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
  • 6.3 Predictive Testing
    • 6.3.1 Overview
    • 6.3.2 Predictive Testing: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Carrier Testing
    • 6.4.1 Overview
    • 6.4.2 Carrier Testing: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Prenatal Testing
    • 6.5.1 Overview
    • 6.5.2 Prenatal Testing: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Newborn Screening
    • 6.6.1 Overview
    • 6.6.2 Newborn Screening: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Others
    • 6.7.1 Overview
    • 6.7.2 Others: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Genetic Testing Services Market - Revenue and Forecast to 2030 - by Disease

  • 7.1 Overview
  • 7.2 North America Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
  • 7.3 Cancer
    • 7.3.1 Overview
    • 7.3.2 Cancer: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Cardiovascular Diseases
    • 7.4.1 Overview
    • 7.4.2 Cardiovascular Diseases: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Metabolic Diseases
    • 7.5.1 Overview
    • 7.5.2 Metabolic Diseases: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Other Diseases
    • 7.6.1 Overview
    • 7.6.2 Other Diseases: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Genetic Testing Services Market - Revenue and Forecast to 2030 - by Service Provider

  • 8.1 Overview
  • 8.2 North America Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
  • 8.3 Hospital-Based Laboratories
    • 8.3.1 Overview
    • 8.3.2 Hospital-Based Laboratories: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Diagnostic Laboratories
    • 8.4.1 Overview
    • 8.4.2 Diagnostic Laboratories: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Genetic Testing Services Market - Country Analysis

  • 9.1 North America
    • 9.1.1 North America Genetic Testing Services Market, by Country
      • 9.1.1.1 US
        • 9.1.1.1.1 Overview
        • 9.1.1.1.2 US: North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.1.3 US: North America Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 9.1.1.1.4 US: North America Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 9.1.1.1.5 US: North America Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 9.1.1.2 Canada
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 Canada: North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.2.3 Canada: North America Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 9.1.1.2.4 Canada: North America Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 9.1.1.2.5 Canada: North America Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 9.1.1.3 Mexico
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 Mexico: North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.3.3 Mexico: North America Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 9.1.1.3.4 Mexico: North America Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 9.1.1.3.5 Mexico: North America Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)

10. Genetic Testing Services Market-Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in Genetic Testing Services Market
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Inorganic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Eurofins Scientific SE
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Exact Sciences Corp
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Laboratory Corp of America Holdings
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 23andMe Holding Co
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Ambry Genetics Corp
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Quest Diagnostics Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Illumina Inc
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 F. Hoffmann-La Roche Ltd
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 NeoGenomics Inc
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Centogene AG
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. North America Genetic Testing Services Market Segmentation
  • Table 2. US: North America Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. US: North America Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US: North America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Canada: North America Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Canada North America Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Canada: North America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Mexico: North America Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Mexico: North America Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Mexico: North America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Recent Organic Growth Strategies in Genetic Testing Services Market
  • Table 12. Recent Inorganic Growth Strategies in the Genetic Testing Services Market
  • Table 13. Glossary of Terms, Genetic Testing Services Market

List Of Figures

  • Figure 1. North America Genetic Testing Services Market Segmentation, By Country
  • Figure 2. North America Genetic Testing Services Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Genetic Testing Services Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. North America Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
  • Figure 6. Predictive Testing: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Carrier Testing: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Prenatal Testing: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Newborn Screening: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Others: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. North America Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
  • Figure 12. Cancer: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Cardiovascular Diseases: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Metabolic Diseases: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Other Diseases: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. North America Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
  • Figure 17. Hospital-Based Laboratories: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Diagnostic Laboratories: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. North America Genetic Testing Services Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 21. North America Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
  • Figure 22. US: North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 23. Canada: North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. Mexico: North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Growth Strategies in Genetic Testing Services Market